- Home
- NBTX vs SSP Comparison
NBTX vs SSP Comparison
Compare NBTX & SSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBTX
- SSP
- Stock Information
- Founded
- NBTX 2003
- SSP 1878
- Country
- NBTX France
- SSP United States
- Employees
- NBTX N/A
- SSP N/A
- Industry
- NBTX Biotechnology: Pharmaceutical Preparations
- SSP Broadcasting
- Sector
- NBTX Health Care
- SSP Industrials
- Exchange
- NBTX Nasdaq
- SSP Nasdaq
- Market Cap
- NBTX 178.7M
- SSP 187.3M
- IPO Year
- NBTX 2020
- SSP 1988
- Fundamental
- Price
- NBTX $3.41
- SSP $2.33
- Analyst Decision
- NBTX Strong Buy
- SSP Buy
- Analyst Count
- NBTX 1
- SSP 2
- Target Price
- NBTX $8.00
- SSP $6.25
- AVG Volume (30 Days)
- NBTX 7.6K
- SSP 772.5K
- Earning Date
- NBTX 04-02-2025
- SSP 05-08-2025
- Dividend Yield
- NBTX N/A
- SSP N/A
- EPS Growth
- NBTX N/A
- SSP N/A
- EPS
- NBTX N/A
- SSP 1.01
- Revenue
- NBTX N/A
- SSP $2,509,772,000.00
- Revenue This Year
- NBTX N/A
- SSP N/A
- Revenue Next Year
- NBTX $221.06
- SSP $9.18
- P/E Ratio
- NBTX N/A
- SSP $2.37
- Revenue Growth
- NBTX N/A
- SSP 9.46
- 52 Week Low
- NBTX $2.76
- SSP $1.36
- 52 Week High
- NBTX $7.51
- SSP $4.65
- Technical
- Relative Strength Index (RSI)
- NBTX 55.19
- SSP 56.16
- Support Level
- NBTX $3.26
- SSP $2.25
- Resistance Level
- NBTX $3.65
- SSP $2.69
- Average True Range (ATR)
- NBTX 0.19
- SSP 0.20
- MACD
- NBTX 0.03
- SSP 0.06
- Stochastic Oscillator
- NBTX 43.75
- SSP 78.85
About NBTX Nanobiotix S.A.
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.
About SSP E.W. Scripps Company (The)
The E W Scripps Co is a media enterprise with interests in local and national media brands. It owns and operates a collection of daily and community newspapers in medium-sized cities in the southern and western portions of the United States. The company's operating segment includes Local Media, Scripps Networks, and Other. It generates maximum revenue from the Local Media segment. The Local Media segment includes local broadcast stations and their related digital operations.